TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6186980

Group type: EXPERIMENTAL
Intervention: Educational intervention (audio-visual presentation and handout materials)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Control group (no educational intervention)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Both groups (experimental and control)
Number of subjects: 127
Study: 31512140

Group type: EXPERIMENTAL
Intervention: CAGIB score
Number of subjects: 1682

Group type: COMPARATOR
Intervention: Child-Pugh score
Number of subjects: 1682

Group type: COMPARATOR
Intervention: MELD score
Number of subjects: 1682

Group type: COMPARATOR
Intervention: MELD-Na score
Number of subjects: 1682

Group type: COMPARATOR
Intervention: NLR score
Number of subjects: 1682
Study: 29912422

Group type: EXPERIMENTAL
Intervention: Guided de-escalation regimen (1 week prasugrel followed by 1 week clopidogrel and guided maintenance therapy)
Number of subjects: 2610

Group type: COMPARATOR
Intervention: Standard treatment with prasugrel for 12 months (control group)
Number of subjects: 2610
Study: 26123574

Group type: EXPERIMENTAL
Intervention: Education intervention
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 245

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 245
Study: 24119678

Group type: EXPERIMENTAL
Intervention: Triplex Doppler ultrasonography (TDU)
Number of subjects: 24
Study: 22052104

Group type: EXPERIMENTAL
Intervention: Icodextrin 4% solution administered intraperitoneally
Number of subjects: 181

Group type: COMPARATOR
Intervention: Traditional treatment (control group)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Icodextrin 4% solution
Number of subjects: 181
Study: 19605605

Group type: EXPERIMENTAL
Intervention: Single patient trials (SPTs) for commonly employed treatments in palliative care, specific drugs not mentioned.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 17192355

Group type: EXPERIMENTAL
Intervention: Recommendations from the American Diabetes Association (ADA) for cardiovascular risk factors in patients with diabetes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recommendations from the American Heart Association (AHA) for cardiovascular disease prevention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Harmonization of AHA and ADA recommendations
Number of subjects: 0
Study: 16301258

Group type: EXPERIMENTAL
Intervention: Silver-coated CVC
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-silversulfadiazine (CH-SS) CVC
Number of subjects: 275

Group type: COMPARATOR
Intervention: Standard CVC
Number of subjects: 275
Study: 11914985

Group type: EXPERIMENTAL
Intervention: Hyperthermia at 434 MHz
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional ultrasound
Number of subjects: 44
Study: 10099044

Group type: EXPERIMENTAL
Intervention: 10 mg famotidine
Number of subjects: 24

Group type: COMPARATOR
Intervention: 200 mg cimetidine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 10150322

Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (2 g/1 g)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cefotaxime (2 g)
Number of subjects: 53
Study: 1967947

Group type: EXPERIMENTAL
Intervention: Vecuronium 0.01 mg kg‐1 as a priming dose followed by 0.1 mg kg‐1 intubation dose
Number of subjects: 32

Group type: COMPARATOR
Intervention: No priming dose of vecuronium
Number of subjects: 32
Study: 7312521

Group type: EXPERIMENTAL
Intervention: 10% catch-trials
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 20% catch-trials
Number of subjects: 33

Group type: COMPARATOR
Intervention: No catch-trials
Number of subjects: 33
Study: 31757262

Group type: EXPERIMENTAL
Intervention: 8 mg/day galantamine
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 16 mg/day galantamine
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 29079603

Group type: EXPERIMENTAL
Intervention: AutoCPAP with SensAwake
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional AutoCPAP
Number of subjects: 48
Study: 26138419

Group type: EXPERIMENTAL
Intervention: miR‐21‐5p overexpression group (adenovirus+0.5 mmol/L H2O2)
Number of subjects: 4

Group type: COMPARATOR
Intervention: H2O2 challenge group (0.5 mmol/L H2O2)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: miR‐21‐5p negative transfection group (adenovirus void+0.5 mmol/L H2O2)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: miR‐21‐5p overexpression group
Number of subjects: 4
Study: 23591949

Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Stretching plus hip/spine disassociation exercises
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Core endurance
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 24
Study: 21640520

Group type: EXPERIMENTAL
Intervention: External-beam pelvic radiotherapy (EBRT)
Number of subjects: 714

Group type: COMPARATOR
Intervention: No additional treatment (NAT)
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: EBRT
Number of subjects: 714

Group type: COMPARATOR
Intervention: NAT
Number of subjects: 714
Study: 19144730

Group type: EXPERIMENTAL
Intervention: Binge meal
Number of subjects: 177

Group type: COMPARATOR
Intervention: Normal meal
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: LOC participants
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Binge meal (overweight and obese girls with LOC)
Number of subjects: 177
Study: 18667139

Group type: EXPERIMENTAL
Intervention: Insulin initiation in patients with T2DM
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term lifestyle modifications
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Family physician's role
Number of subjects: 0
Study: 15852734

Group type: EXPERIMENTAL
Intervention: Chemotherapy or chemoradiation followed by surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Definitive chemoradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 0
Study: 11226106

Group type: EXPERIMENTAL
Intervention: LR Before group (12 mL/kg of LR solution within 20 min before spinal anesthesia)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: LR After group (12 mL/kg of LR solution within 20 min starting immediately after spinal anesthesia)
Number of subjects: 75

Group type: COMPARATOR
Intervention: No Infusion group (no LR solution given)
Number of subjects: 75
Study: 9692270

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Treatment (CBT) plus disulfiram
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Twelve Step Facilitation (TSF) plus disulfiram
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Clinical Management (CM) plus disulfiram
Number of subjects: 122

Group type: COMPARATOR
Intervention: Cognitive Behavioral Treatment (CBT) plus no medication
Number of subjects: 122

Group type: COMPARATOR
Intervention: Twelve Step Facilitation (TSF) plus no medication
Number of subjects: 122
Study: 8168892

Group type: EXPERIMENTAL
Intervention: Contaminated open extremity fractures
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Inclusion of patients with open fractures in studies
Number of subjects: 41
Study: 3300140

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional insulin therapy (CIT)
Number of subjects: 24
Study: 31845341

Group type: EXPERIMENTAL
Intervention: Ionized hypocalcaemia
Number of subjects: 226
Study: 29782968

Group type: EXPERIMENTAL
Intervention: Neurofeedback session aimed at increasing deoxygenated hemoglobin (deoxy-Hb)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Neurofeedback session aimed at decreasing oxygenated hemoglobin (oxy-Hb)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Neurofeedback session
Number of subjects: 48
Study: 28836796

Group type: EXPERIMENTAL
Intervention: CRAFT (12-14 sessions)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Treatment Entry Training (TEnT) (4-6 sessions)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Al-Anon/Nar-Anon Facilitation (ANF) (12-14 sessions)
Number of subjects: 115
Study: 26057863

Group type: EXPERIMENTAL
Intervention: AT20-KLH vaccination
Number of subjects: 10
Study: 22336488

Group type: EXPERIMENTAL
Intervention: Eltrombopag powder for oral suspension (PfOS) 25 mg administered fasted
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eltrombopag PfOS with a high‐calcium meal
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eltrombopag PfOS 2 hours after a high‐calcium meal
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eltrombopag PfOS 2 hours before a high‐calcium meal
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Eltrombopag PfOS
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Adverse events (AEs)
Number of subjects: 40
Study: 20171661

Group type: EXPERIMENTAL
Intervention: Lemon juice
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Increased fluid intake
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Potassium citrate
Number of subjects: 24
Study: 17337249

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gabapentin (GBP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16324542

Group type: EXPERIMENTAL
Intervention: Cis‐Atracurium (muscle relaxant)
Number of subjects: 13

Group type: COMPARATOR
Intervention: No muscle relaxant
Number of subjects: 13
Study: 12218279

Group type: EXPERIMENTAL
Intervention: 10% chlorhexidine varnish (Chlorzoin)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo varnish
Number of subjects: 75
Study: 9484761

Group type: EXPERIMENTAL
Intervention: BT563 with cyclosporine from day of transplantation (group A)
Number of subjects: 51

Group type: COMPARATOR
Intervention: BT563 with cyclosporine starting on day 3 (group B)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Both groups A and B
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: BT563 presence during acute rejection
Number of subjects: 51
Study: 7707139

Group type: EXPERIMENTAL
Intervention: Participation in a 3-month international study program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Not participating in the international study program
Number of subjects: 28
Study: 2709216

Group type: EXPERIMENTAL
Intervention: Diflunisal 1,000 mg administered 30 minutes preoperatively
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Diflunisal 1,000 mg administered 30 minutes postoperatively
Number of subjects: 20
Study: 75692

Group type: EXPERIMENTAL
Intervention: Intra-amniotic hyperosmolar urea and 5 mg. of prostaglandin F2alpha (PGF2alpha)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intra-amniotic hyperosmolar urea alone
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intra-amniotic hyperosmolar urea and 10 mg. of prostaglandin F2alpha
Number of subjects: 150
Study: 30615117

Group type: EXPERIMENTAL
Intervention: Vedolizumab plus corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vedolizumab alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study: 29486753

Group type: EXPERIMENTAL
Intervention: WHO-5A based comprehensive tobacco control program (adapted 5A group counseling supported by social media and traditional health education)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 315
Study: 27581505

Group type: EXPERIMENTAL
Intervention: Goal setting group (n = 143)
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Goal checking group (n = 132)
Number of subjects: 545

Group type: COMPARATOR
Intervention: Control group (n = 270)
Number of subjects: 545

Group type: COMPARATOR
Intervention: All groups (overall figures)
Number of subjects: 545

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for employed women
Number of subjects: 545

Group type: EXPERIMENTAL
Intervention: Subgroup analysis for unemployed men
Number of subjects: 545
Study: 24667509

Group type: EXPERIMENTAL
Intervention: Intervention group (8-hour case-based curriculum focused on six mentoring competencies)
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 283

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 283
Study: 22964475

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (800 IU/day)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Calcium (2 g/day)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Calcium (2 g/day) and Vitamin D3 (800 IU/day)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study: 19997906

Group type: EXPERIMENTAL
Intervention: Active treatment (cognitive-enhancing drug)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment control group
Number of subjects: 0
Study: 18073061

Group type: EXPERIMENTAL
Intervention: Lamivudine (therapeutic group)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Lamivudine (preventive therapeutic group)
Number of subjects: 13
Study: 16118574

Group type: EXPERIMENTAL
Intervention: Electromyostimulation (EMS) training for 8 weeks, 32 sessions of isometric EMS
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no EMS training)
Number of subjects: 20
Study: 11872516

Group type: EXPERIMENTAL
Intervention: Focused individual psychotherapy (up to 30 sessions)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Psychoeducational group therapy (up to 18 sessions)
Number of subjects: 71
Study: 10603440

Group type: EXPERIMENTAL
Intervention: Pranlukast
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0
Study: 8682011

Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 214

Group type: COMPARATOR
Intervention: Control (non fibrinolytic medical therapy)
Number of subjects: 214
Study: 2233906

Group type: EXPERIMENTAL
Intervention: H. influenzae type b polysaccharide‐diphtheria toxoid conjugate vaccine (PRP‐D)
Number of subjects: 2102

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 2102

Group type: EXPERIMENTAL
Intervention: H. influenzae type b polysaccharide‐diphtheria toxoid conjugate vaccine (PRP‐D) after three doses
Number of subjects: 2102
Study: 582880

Group type: EXPERIMENTAL
Intervention: Homatropine methylbromide plus phenobarbital in a 20% alcohol solution
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 30953544

Group type: EXPERIMENTAL
Intervention: Active 2-mA tDCS for 20 min once a day for 10 consecutive weekdays
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham stimulation for 20 min once a day for 10 consecutive weekdays
Number of subjects: 70
Study: 28165268

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE) therapy
Number of subjects: 85
Study: 25843243

Group type: EXPERIMENTAL
Intervention: 100 kVp with 270 mgI/mL iodixanol
Number of subjects: 231

Group type: COMPARATOR
Intervention: 120-kVp filtered back projection
Number of subjects: 231
Study: 23648282

Group type: EXPERIMENTAL
Intervention: Theta burst transcranial magnetic stimulation (TBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1Hz repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 0
Study: 21252738

Group type: EXPERIMENTAL
Intervention: Oxytocin administration for 12 hours after membrane rupture
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Oxytocin administration
Number of subjects: 1347
Study: 19723905

Group type: EXPERIMENTAL
Intervention: Intravenous epoprostenol (Flolan)
Number of subjects: 102
Study: 17335723

Group type: EXPERIMENTAL
Intervention: Transdermal buprenorphine
Number of subjects: 1188
Study: 15855569

Group type: EXPERIMENTAL
Intervention: Oral insulin (7.5 mg/day)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Oral insulin (7.5 mg/day) in subgroup with IAA levels > or =80 nU/ml (n = 263)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Placebo in subgroup with IAA levels > or =80 nU/ml (n = 263)
Number of subjects: 372
Study: 12477321

Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 747

Group type: COMPARATOR
Intervention: Ceftriaxone/Cefpodoxime
Number of subjects: 747
Study: 9859998

Group type: EXPERIMENTAL
Intervention: 0.5- to 1-minute MMC
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 3- to 5-minute MMC
Number of subjects: 124

Group type: COMPARATOR
Intervention: No MMC
Number of subjects: 124
Study: 10150674

Group type: EXPERIMENTAL
Intervention: Laser etching (CO2 laser)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acid etching (orthophosphoric acid)
Number of subjects: 0
Study: 2598585

Group type: EXPERIMENTAL
Intervention: Meglumine iothalamate (Conray 280) with adrenaline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Meglumine iothalamate (Conray 280) without adrenaline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium meglumine ioxaglate (Hexabrix 320) without adrenaline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sodium meglumine ioxaglate (Hexabrix 320) with adrenaline
Number of subjects: 0
Study: 788655

Group type: EXPERIMENTAL
Intervention: Antibiotics (Ampicillin)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Non-antibiotic treatment
Number of subjects: 58
Study: 31974806

Group type: EXPERIMENTAL
Intervention: RW program delivered during home visit
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: RW program delivered in group presentation followed by home visit
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: RW program (both delivery methods)
Number of subjects: 119
Study: 31605521

Group type: EXPERIMENTAL
Intervention: Load blinding (BLI)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Load nonblinding (nBLI)
Number of subjects: 32
Study: 27590273

Group type: EXPERIMENTAL
Intervention: Directly observed therapy with fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Referral to community mental health treatment
Number of subjects: 0
Study: 25807800

Group type: EXPERIMENTAL
Intervention: Ingested anti-rotavirus IgY
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 100
Study: 23088748

Group type: EXPERIMENTAL
Intervention: Subcutaneous insulin therapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Intravenous insulin therapy
Number of subjects: 58
Study: 21713745

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP) 5mg/kg intravenously after induction of anesthesia
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MP)
Number of subjects: 120
Study: 19702616

Group type: EXPERIMENTAL
Intervention: Full bedrail use
Number of subjects: 1092

Group type: EXPERIMENTAL
Intervention: Nurses' description of patients as immobile and very or slightly confused
Number of subjects: 1092

Group type: COMPARATOR
Intervention: Older patients
Number of subjects: 1092
Study: 16432810

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 246

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 246
Study: 15606395

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg twice daily for 12 weeks) + Infliximab (5 mg/kg at weeks 6, 8, and 12)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo + Infliximab (5 mg/kg at weeks 6, 8, and 12)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg twice daily for 12 weeks)
Number of subjects: 24
Study: 11678745

Group type: EXPERIMENTAL
Intervention: Computer-generated information system
Number of subjects: 40

Group type: COMPARATOR
Intervention: Leaflet
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preference for information system
Number of subjects: 40
Study: 9401833

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg
Number of subjects: 28

Group type: COMPARATOR
Intervention: Felodipine ER 5 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 28
Study: 7505563

Group type: EXPERIMENTAL
Intervention: Finasteride, 5 mg for 24 months
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 3303006

Group type: EXPERIMENTAL
Intervention: Genetic amniocentesis
Number of subjects: 2264

Group type: COMPARATOR
Intervention: Control group (high-risk women offered amniocentesis)
Number of subjects: 2264
Study: 28365809

Group type: EXPERIMENTAL
Intervention: Sensodyne® Rapid Relief (occluding toothpaste)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Crest® Decay Prevention (non-occluding toothpaste)
Number of subjects: 19
Study: 26837214

Group type: EXPERIMENTAL
Intervention: Mental Health First Aid training (MHFA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (waitlist)
Number of subjects: 0
Study: 25609176

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide injections (n = 16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional treatment (n = 16)
Number of subjects: 32
Study: 23376898

Group type: EXPERIMENTAL
Intervention: New topographic indices computed from digitized images of the Placido rings
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group (normal eyes)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Keratoconus group (KC)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Keratoconus suspect group
Number of subjects: 124
Study: 20712153

Group type: EXPERIMENTAL
Intervention: Use of Google Earth as an educational tool in a history of psychology class
Number of subjects: 0
Study: 18833862

Group type: EXPERIMENTAL
Intervention: Aluminous oxide abrasion (27 microm, 40 psi)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aluminous oxide abrasion (50 microm, 40 psi)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Hand instrument (excavator)
Number of subjects: 4
Study: 16632411

Group type: EXPERIMENTAL
Intervention: Natural dietary sources of TFA (milk fat enriched in TFA, approximately 20 g/100 g of total fatty acids)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Industrial dietary sources of TFA (partially hydrogenated vegetable oils, PHVO)
Number of subjects: 46
Study: 14658948

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64